Research grant empowers future leaders in clinical research to advance breakthroughs in the prevention, detection, diagnosis and treatment of NMIBC…
Parsippany, NJ – November 12, 2025 – Ferring Pharmaceuticals thanks New Jersey and Michigan for recognizing November as Clostridioides difficile…
Three abstracts to be presented at the 101st Annual Meeting of the Western Section of the American Urological Association, including…
Analyses from the two Phase 3 RITA trials evaluate both the suitability of age-based dosing as well as the tolerability…
Oral presentation highlights microbiome restoration through six months with REBYOTA from Phase 3b CDI-SCOPE trial New data from CDI-SCOPE evaluating…
Results from two real-world studies, presented at IDWeek 2025, include initial registry findings and highlight consistent efficacy and safety of…
New, real-world experience from a private clinical practice presented at the 99th Annual Meeting of the North Central Section of…
TV personality Jessel Taank, Olympic gold medalist Tara Lipinski and reproductive endocrinologist Dr. Lucky Sekhon join Ferring to highlight the…
Data presented at Digestive Disease Week (DDW) 2025 demonstrated safety and treatment success in patients treated for recurrent C. Diff…
Ferring expands production of ADSTILADRIN with new Parsippany, NJ, facility, adding to existing manufacturing sites in Kuopio, Finland Capacity expansion…